Stem cell therapy shows promise in repairing brain damage
By Dr. Matthew Watson
Stem cell therapy shows promise in repairing brain damage even hours after stroke occurs
Durham, NC Stroke is a major health concern and is a leading cause of death in the United States, according to the Center for Disease Control. Despite significant research efforts, developing treatments that ensure complete recovery for stroke patients poses an extreme challenge, especially when more than a few hours have passed between onset of the stroke and administration of treatment.
However, a new study released today in STEM CELLS Translational Medicine indicates that endothelial precursor cells, which are found in the bone marrow, umbilical cord blood, and as very rare cells in peripheral blood, could make a significant difference for these patients recovery even in the later stages of stroke. In animal studies, the treatment minimized the initial brain injury and helped repair the stroke damage.
Previous studies indicated that stem/progenitor cells derived from human umbilical cord blood (hUCB) improved functional recovery in stroke models, noted Branislava Janic, Ph.D., a member of Henry Ford Health Systems Cellular and Molecular Imaging Laboratory in Detroit and lead author of the study. We wanted to examine the effect of hUCB-derived AC133+ endothelial progenitor cells (EPCs) on stroke development and resolution in rats.
Dr. Janic and his team injected rats that had suffered strokes with the stem cells. When they later examined the animals using MRI, they found that the transplanted cells had selectively migrated to the injured area and that the stem cells stopped the tissue damage from spreading, instigated regeneration, and also affected the time course for stroke resolution. A significant decrease in lesion size also was observed, at a dose of 10 million cells, as early as seven days after the strokes onset.
This led us to conclude that cord blood-derived EPCs can significantly contribute to developing more effective treatments that allow broader time period for intervention, minimize the initial brain injury and help repair the damage in later post-stroke phases, Dr. Janic said.
The early signs of stroke are often unrecognized, and many patients cannot take advantage of clot-busting treatments within the required few hours after stroke onset, said Anthony Atala, M.D., editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine. In this animal study, a combination of stem cells shows promise for healing stroke damage when administered 24 hours after the stroke.
###
The full article, Intravenous administration of human umbilical cord blood derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume magnetic resonance imaging (MRI) and histological findings, can be accessed at http://www.stemcellstm.com.
About STEM CELLS Translational Medicine: STEM CELLS TRANSLATIONAL MEDICINE (SCTM), published by AlphaMed Press, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.
More here:
Stem cell therapy shows promise in repairing brain damage
House panel trains sights on unregulated stem-cell therapy in PH
By JoanneRUSSELL25
By: InterAksyon.com August 9, 2013 10:02 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines - The controversy over unregulated stem cell procedures in the country, including the role of unlicensed foreign doctors, has reached Congress, from where several alleged victims of malpractice came. The vice chairman of the House blue-ribbon panel is set to deliver a privileged speech Monday ahead of hearings on the current state of things in the stem cell therapy practice in the country, where experts warned earlier the "fad-like" atmosphere poses serious threat to public health and safety.
Rep. Doy Leachon of Oriental Mindoro is expected to train his sights on, among others: the unethical practice of stem cell therapy without Food and Drug Administration (FDA) approval and on unapproved indications; the charging of exorbitant fees for still-experimental procedures; the criminal liabilities of doctors who prey on the miseries of desperate sick patients; a review of the potential conflict of interest, unethical conduct of self-promotion and violation of FDA rules in pushing stem cell therapy and charging of fees involving the Philippine Medical Association (PMA) and Philippine Society for Stem Cell Medicine (PSSCM).
Leachon wants the academe, ethics experts and the Philippine College of Physicians to shed light on the multidimensional controversy.
The House inquiry may also focus on the deaths of two congressmen who allegedly died after undergoing stem cell therapy; and the case of Dangerous Drugs Board chairman Antonio Villar, who developed adverse reactions.
Expected to be summoned to the House hearings, besides representatives of the PMA and PSSCM are officials of the FDA, Department of Health, PRC, Securities and Exchange Commission, Bureau of Immigration, Bureau of Internal Revenue and other stakeholders.
Earlier this week, the Professional Regulations Commission (PRC) served notice it would require special permits from foreign doctors who conduct stem cell procedures in the country. It warned that those failing to do so, as well as their local partners, face criminals charges for medical malpractice.
For his part, Leachon--saying a class suit is possible against doctors in cases where the stem cell therapy was found to have caused deaths and adverse reactions--encouraged patients victimized by "unscrupulous con artists and who developed side effects" to report to his office.
Leachon, a lawyer, was a TOYM awardee in public service in 2011.
See original here:
House panel trains sights on unregulated stem-cell therapy in PH
6 weeks post-op Adipose Stem Cell Therapy – Video
By Dr. Matthew Watson
6 weeks post-op Adipose Stem Cell Therapy
"Dugan" 6 weeks post-op Adipose Stem Cell Therapy. Visit Kindred-caninesinmotion.org.
By: Joyce Gerardi
Read the original post:
6 weeks post-op Adipose Stem Cell Therapy - Video
Whoifwhat: Stem Cell Therapy- Knees, Hip, Back, etc.! – Video
By LizaAVILA
Whoifwhat: Stem Cell Therapy- Knees, Hip, Back, etc.!
It works: Now in St. Louis, New York Phily: coming to your town soon ! Using stem cells from belly fat ( got any) platelets to mark area an injection is ...
By: whoifwhat
Continued here:
Whoifwhat: Stem Cell Therapy- Knees, Hip, Back, etc.! - Video
Stem Cell Therapy Treatment for Spastic Cerebral Palsy by Dr Alok Sharma, Mumbai, India. – Video
By LizaAVILA
Stem Cell Therapy Treatment for Spastic Cerebral Palsy by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Spastic Cerebral Palsy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Droo...
By: Neurogen Brain and Spine Institute
Read this article:
Stem Cell Therapy Treatment for Spastic Cerebral Palsy by Dr Alok Sharma, Mumbai, India. - Video
Foreign doctors need permit for stem cell therapy
By JoanneRUSSELL25
MANILA - Foreign doctors are now required to secure a permit to perform stem cell therapy in the country or face criminal liability.
The Professional Regulation Commission (PRC)s Board of Medicine (BOM) made the announcement yesterday, explaining that the requirement is part of government efforts to regulate the practice of stem cell therapy in the country to ensure the safety of patients.
In a statement, the BOM said foreign physicians who intend to practice stem cell therapy here must obtain special temporary permit from the PRC to avoid being charged with medical malpractice.
Even local doctors who have aided foreign physicians illegal practice of stem cell therapy shall be also held criminally liable, the BOM added.
To secure the special temporary permit, a foreign doctor must submit proof of education and actual practice in the field of stem cell therapy and current license authenticated by the Philippine embassy and the embassy in the country of origin.
The board said physicians should have acquired the necessary education, supervised training and extensive clinical experience prior to performing the treatment. It noted that the argument that stem cell therapy falls under the general practice of medicine since it only involves injection of stem cell solution is erroneous.
As professionals, physicians should be able to conduct self-assessment and self-evaluation regarding what they can and what they should not do, they added.
The BOM also noted that stem cell therapy should be practiced only in hospitals and clinics licensed by the Department of Heath for assurance that these medical facilities have the necessary manpower and equipment to prevent risks and hazards to patients.
The board also warned patients desiring to undergo stem cell therapy abroad to first verify the status of clinics and hospitals as well as practitioners from regulatory authorities.
Earlier, the Food and Drug Administration and the Philippine Medical Association (PMA) reported receiving numerous complaints of foreign doctors performing stem cell therapy in hotels and other non-medical facilities. The PMA said foreign doctors injected patients with animal-based stem cells at P1 million per shot, but these foreigners are not even licensed to practice medicine in the country.
More here:
Foreign doctors need permit for stem cell therapy
PRC: Foreign docs doing stem cell therapy in PH must get special temporary permits
By raymumme
By: Jet Villa, InterAksyon.com August 6, 2013 4:34 PM
InterAksyon.com The online news portal of TV5
MANILA, Philippines - Amid a flurry of reports about unregulated procedures that have led to serious injury or even deaths, the Professional Regulation Commission (PRC) is now requiring foreign doctors wishing to practice stem cell therapy in the Philippines to obtain a special temporary permit (STP).
In a position statement, the Professional Regulatory Board of Medicine (PRBOM) said foreign doctors must submit proof of education, training and clinical experience and actual practice in the field of stem cell therapy, plus a current license to practice authenticated by the Philippine Embassy/Consulate in the country of origin when they apply for the special permits.
The board warned: Any foreign physician who practices the professionwithout a STP will be criminally liable for illegal practice of medicine.And, it added, those who have aided and abetted the foreign physicianspractice of the profession are also criminally liable.
The position paper was signed by PRBOM chairman Dr. Edgardo Fernando and members doctors Miguel Noche Jr., Florentino Doble, Restituto de Ocampo, Jose Cueto Jr., and Mildred Pareja.
Controversy hounds new group
The position statement on stem cell therapy was issued amid a growing rift among doctors over recent controversial cases, including several lawmakers who had procedures done, but whose conditions worsened.
One newly-founded group of doctors doing stem-cell transplant, the Philippine Society of Stem Cell Medicine (PSSCM), has been pitted by the controversy against the Philippine College of Physicians, Philippine Society of General Internal Medicine (PSGIM), Philippine Society of Hematology and Blood Transfusion (PSHBT) andPhilippine College of Chest Physicians (PCCP). The latter groups all believe thatPSSCM's practices are unethical as it charges huge fees from patients for stem cell procedures that are still under clinical trial.
The PRBOM has backed the Department of Health in issuing Administrative Order 2013-0012 providing the guidelines for stem cell, cell-based therapy in the country. "The practice of stem cell therapy does not constitute standard care at the present time. The claim that it offers cure to numerous diseases and conditions has not been proven through scientific research and documentation, the PRBOM said. Right now, it said, "there is difficulty verifying claims of practitioners and institutions regarding the effectivity ofavailable treatment modalities.
Link:
PRC: Foreign docs doing stem cell therapy in PH must get special temporary permits
NewsLife: PCP pushes for more studies on stem cell therapy – Video
By raymumme
NewsLife: PCP pushes for more studies on stem cell therapy
NewsLife - PCP pushes for more studies on stem cell therapy (Reported By: Dina Paguibitan) - [July 30, 2013] For more news, visit: #9659;http://www.ptvnews.ph Dow...
By: PTV PH
Link:
NewsLife: PCP pushes for more studies on stem cell therapy - Video
Adult Stem Cell Therapy for Back Pain – Video
By Dr. Matthew Watson
Adult Stem Cell Therapy for Back Pain
A registered nurse describes her experience with an adult stem cell therapy procedure for back pain. More information at medrebels.org.
By: medrebels1
Go here to read the rest:
Adult Stem Cell Therapy for Back Pain - Video
Advanced Topics – Stem Cell Therapy part 1 – Video
By Sykes24Tracey
Advanced Topics - Stem Cell Therapy part 1
By: Jesse Matteson
Here is the original post:
Advanced Topics - Stem Cell Therapy part 1 - Video
Can Genetic Engineering Save the Orange, and Vice Versa? – New York Times (blog)
By Dr. Matthew Watson
New York Times (blog) | Can Genetic Engineering Save the Orange, and Vice Versa? New York Times (blog) Ricke Kress of Southern Gardens Citrus has high hopes for his secret plot of test trees Richard Perry/The New York Times Ricke Kress of Southern Gardens Citrus has high hopes for his secret plot of test trees, some of which are genetically modified. In ... |
O’Malley Highlights How Biotechnology Benefits The Economy – CBS Local
By Dr. Matthew Watson
O'Malley Highlights How Biotechnology Benefits The Economy CBS Local ANNAPOLIS, Md. (WJZ) — New technologies being developed in the University of Maryland biopark are making a difference to the state's economy. Pat Warren reports on some of the progress. Governor Martin O'Malley credits Maryland's biopark with ... O'Malley to highlight biotechnologyMiamiHerald.com |
Ghanaian Journalists Trained In Biotechnology – Ghana
By Dr. Matthew Watson
Ghanaian Journalists Trained In Biotechnology Ghana The Ghana Journalists Association (GJA), in collaboration with Africa Harvest Foundation International (Africa Harvest), has organised a biosafety workshop for Ghanaian journalists to enable them to report issues on biotechnology more accurately. |
INEOS Bio’s New Bio Technology Process Creates Fuel And Electricity From … – International Business Times
By Dr. Matthew Watson
International Business Times | INEOS Bio's New Bio Technology Process Creates Fuel And Electricity From ... International Business Times A bio energy producer in Florida said Wednesday that it produced mass quantities of ethanol from waste and nonfood matter, a development that could have a significant impact on the fuel industry and the environment. |
Amid budget cuts, N.C. Biotechnology Center asking workers to voluntarily resign – Triangle Business Journal
By Dr. Matthew Watson
Amid budget cuts, N.C. Biotechnology Center asking workers to voluntarily resign Triangle Business Journal The North Carolina Biotechnology Center has started a “voluntary separation program” in attempts to avoid layoffs. The move, targeting the organization's veteran employees, is in response to the $4.6 million cut in funding for the center that was ... |
UNR hatches biotechnology startup DxDiscovery – Sparks Today
By Dr. Matthew Watson
UNR hatches biotechnology startup DxDiscovery Sparks Today The startup, a biotechnology company created by UNR researchers, needed a numbers guy. It would be Maine's introduction to the fast-paced and crazy world of startups. Only in a startup, for example, would a person find himself switching from an ... |
Pay-for-Eggs Legislation: A Comment on Risk
By Dr. Matthew Watson
the eggs legislation item today has responded to a comment filed
by two persons opposed to the measure that would remove the ban in
California on paying women for their eggs for scientific research.
executive director of the Genetic Literacy Project.
“Diane and Nancy, I'm shocked that
you are either unaware or do not acknowledge that there are studies
of oocyte retrieval surgeries that show very persuasively that the
potential harm from this procedure is manageable. While you refer to 'stories' of women being harmed--that's called anecdotal
evidence and is the antithesis of science--you ignore the established
research in this area, which makes it clear that you are reacting
hysterically rather than responding to empirical evidence. I would
suggest that you read the National Academies Press workshop report:
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell
Research (http://www.nap.edu/catalog.php?record_id=11832).
It cites numerous studies, including a German study that examined the
outcome of approximately 380,000 oocyte retrieval surgeries during
2000-2004. For the procedures for which there was information, the
rate of complications was very low: only 0.002 percent—2 in every
100,000—had complications that required surgery to correct.
“Studies have also examined the
potential risks of retrieval for a woman's future fertility.
“According to one large study, the
rate of infection after oocyte retrieval was about 1 in every 200 IVF
cycles, and surgery is needed to treat pelvic abscesses in less than
1 in 1,000 IVF cycles.
“About five hundred egg donations
take place in Canada each year, according to the Canadian Fertility
and Andrology Society.The CFAS told me that, between 2001 and 2010,
only two donors in Canada, out of a total of 4,177 donations,
suffered from “severe” OHSS, which usually involves
hospitalization. Fourteen others had “moderate” OHSS. These
numbers are collected in a database called the Canadian Assisted
Reproductive Technologies Registry.
“So sure, you can find your 'stories' but they do not represent a scientific review of the available
data--you are trying to legislate based on fear. That's not science;
that's the dark ages, and it's exactly the tactics used by
anti-abortionists (and indeed by organizations like the Center for
Genetics and Society which opposes such beneficial advances as
mitochondrial replacement surgery).
“Furthermore, because women have a
set of two ovaries and two fallopian tubes, they can remain fertile
even if one set is damaged, and there is no evidence that both might
be threatened simultaneously by the side effects of retrieval
surgery.
“Today doctors have had two decades
of experience with the use of hormone treatments to maximize the
number of eggs that can be harvested from a woman, and they have
become quite proficient in the production of oocytes. During that
time they have also worked to improve the safety of the procedure and
decrease the potential risks. Despite these improvements some risk
will remain, because hormones have a powerful effect on the body—they
could not increase egg production so dramatically if this were not
true—and anything with a powerful effect on the body has the
potential for harmful side effects as well.
“Egg donations are done for a reason.
There are risks and benefits. For you to exaggerate the risks based
on 'stories' and ignore the evidence is unconscionable.
It's exactly what anti-abortion groups do and what opponents of
genetically modified foods do--you promote fear around manageable (or
in the case of GMOs, negligible) risk.
“Your call for 'further studies' is the age old technique of reactionaries trying to control other
people and impose their values on other people. You know darned well,
because of your fundamental ideological opposition to this procedure,
no study results could ever meet your standard of acceptability.
“You are trying to control other
women's bodies, claiming you have superior knowledge and
wisdom--those are pro-life talking points. Your views, and that of
the organizations that you represent, are illiberal.”
Comment re Pay-for-Eggs Item and Forbes Article
By Dr. Matthew Watson
Sacramento Bee has filed a comment in connection with an item today on the California Stem Cell Report. The item dealt with the California pay-for-eggs bill, which was also the subject of an op-ed piece in The Sacramento Bee as well as an article yesterday on the Forbes
magazine website that discussed the op-ed piece critically.
today.
Nancy Scheper-Hughes, a professor of anthropology at UC Berkeley and
director of Organs Watch. Diane Tober, associate executive director of the Center for
Genetics and Society of Berkeley, was the other author.
“Dr. Diane Tober and Prof. Nancy
Scheper-Hughes are 'pro choice' social scientists who are
concerned about the absence of any evidence-based medicine on the
long term effects of hyper-stimulation for oocyte (egg) production in
young women research subjects. We are not concerned about abortion,
right to life, or obstructing needed and valuable research on
stem cells. We are concerned about the safety for potential research
subjects who are being actively recruited to participate in
invasive medical procedures without any medical research
studies on the possible risks and consequences of egg multiplication
and extraction. We are on record that we fully support stem
cell research but not at the expense of unprotected egg donors.”
Pay-for-Eggs Legislation Now Before California Gov. Jerry Brown
By Dr. Matthew Watson
officially on Gov. Jerry Brown's desk, awaiting his signature or
veto.
Susan Bonilla, D-Concord, was sent to the governor at 4:45 p.m. PDT
yesterday. On July 1, it easily won legislative approval and
has been held in legislative processing since then. The governor has
12 days to act on the measure or it becomes law without his
signature.
ban on payment to women for their eggs for scientific purposes.
Currently women who provide their eggs for fertility purposes can be
compensated. Fees run as high as $50,000 in some cases, depending on
the characteristics of the woman providing the eggs, but generally
are in the $10,000 range or less. The bill does not affect the ban on
the use of funds from the California stem cell agency to compensate
egg providers.
billion-a-year fertility industry, which is backing it on motherhood
and sexual equity grounds. Supporters say women should receive
payment for their eggs just as men are paid for their sperm. They
also argue that more eggs are needed for research into fertility
problems. In the stem cell field, scientists have also said it is
nearly impossible to find women who will provide eggs unless they are
paid.
stimulating production of eggs can be risky or dangerous. They say
that the longterm effects of the process have not been studied well.
They also argue that it will lead to exploitation of low income and
minority women to produce eggs that then can become a profitable
commodity for the largely unregulated fertility industry. (For more
informationon on the bill, see here, here and here.)
Bee, opponents cited the late philosopher Ivan Illich, who was much admired by Jerry Brown, who considered him a friend. Illich was quoted as warning "against the processes of medical
industries which 'create new needs and control their satisfaction and
turn human beings and their creativity into objects.'"
committed to signing the bill.
yesterday in an article on the Forbes magazine website by Jon Entine.
He wrote,
“Should activist groups, working
through legislators, exercise their control over women’s
reproduction? Do we really 'own' our own bodies? Or does that tenet
only hold when nanny groups say it’s okay?”
The egg legislation may have implications for
regulation of stem cell research by the state Department of Public
Health(again not involving the California stem cell agency). Last
month the California Stem Cell Report asked Hank Greely, a Stanford
law professor and chair of the state department's Human Stem Cell Research Advisory Committee, about the measure. He replied,
“Well, if (when?) AB 926 is signed, I
think our committee should meet to consider what recommendations we
would make to the (the department) as a result of the bill. Those
recommendations could lead, if the committee and the department
agree, to a revision of the state guidelines. As a matter of
law, a statute, particularly a subsequent statute, trumps a guideline
where they are in conflict, but basically I expect we'll see what the
committee thinks and what the department decides. I don't wish
to guess at the results of either process.”
publicly during the debate on the legislation deals with whether human eggs provided with compensation would be subject to state sales tax at any stage in the process. A check of the tax code, however, makes it
clear that eggs are tax free. The code states that “any human body
parts held in a bank for medical purposes, shall be exempt from
taxation for any purpose." The definition of “bank”
includes research facilities, and "medical purposes" includes research.
Skimpy Coverage of Alpha Clinic Concept Approval
By Dr. Matthew Watson
California stem cell agency's ambitious, $70 million Alpha clinic
plan has been quite light but does include one article in the Los
Angeles Times, the state's largest circulation newspaper.
week by the agency's board with RFAs scheduled to be posted in
October. The agency is seeking to build a basis for a robust stem
cell clinic business in California that would have an international
reach and give the state dominance in the industry.
week quoted CIRM President Alan Trounson as saying in 2010 about
agency's goals.
“If we went 10 years and had no
clinical treatments, it would be a failure. We need to demonstrate
that we are starting a whole new medical revolution.”
voters in 2004 and funded with $3 billion in borrowed money. It will
run out of funds for new grants in 2017.
the plan this week in a story that said,
“The opportunity to run trails under
the well-funded CIRM could be a boon for CROs (contract research
organizations)....But the difficulties of handling the stem cells and
gathering enough patients to enroll in a trial may prove daunting for whatever
company tries to conduct the trials.”
Kevin McCormack as saying,
“No one has reached out to us yet
because the specific details of what we are looking for in the
clinics have not yet been decided.”
Alpha clinic plan was GenNews.